Cyclodextrin based artificial enzymes
Using cyclodextrins (CDs) as scaffolds for artificial enzymes has emerged as a promising strategy for improving catalytic processes. Due to
A forum for researchers, students and applicants in the field of cyclodextrin technology
Using cyclodextrins (CDs) as scaffolds for artificial enzymes has emerged as a promising strategy for improving catalytic processes. Due to
Fosaprepitant has been initially approved in 2008 in the USA. In August, 2023, an improved composition also containing SBECD has